Front Biosci (Elite Ed). 2010 Jun 1;2:1099-104.

Biomarkers in lung cancer.

Bearz A, Berretta M, Cappellani A, Lleshi A, Berto E, Fratino L, Tirelli U.

Department of Medical Oncology, CRO-IRCCS, National Cancer Institute, Aviano, PN, Italy. abearz@cro.it

Abstract
Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.

«  indice delle pubblicazioni più recenti